Evidence map›Paper›PMID 37342204›Full record

ArticleThe journal of physical chemistry. C, Nanomaterials and interfaces2023

Investigation of Iron(III) Tetraphenylporphyrin as a Redox Flow Battery Anolyte: Unexpected Side Reactivity with the Electrolyte.

Nathan H Mitchell, Noémie Elgrishi

Abstract read
In one paragraph

Article in The journal of physical chemistry. C, Nanomaterials and interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Operando Spectroelectrochemistry Unravels the Mechanism of COAngewandte Chemie (International ed. in English) · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan H MitchellLouisiana State University, Baton Rouge, Louisiana 70803, USA.ORCID https://orcid.org/0000-0002-4249-7612
Noémie ElgrishiLouisiana State University, Baton Rouge, Louisiana 70803, USA.ORCID https://orcid.org/0000-0001-9776-5031

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Redox flow batteries (RFBs) present an opportunity to bridge the gap between the intermittent availability of green energy sources and the need for on-demand grid level energy storage. While aqueous vanadium-based redox flow batteries have been commercialized, they are limited by the constraints of using water as an electrochemical solvent. Nonaqueous redox flow battery systems can be used to produce high voltage batteries due to the larger electrochemical window in nonaqueous solvents and the ability to tune the redox properties of active materials through functionalization. Iron porphyrins, a class of organometallic macrocycles, have been the subject of many studies for their photocatalytic and electrocatalytic properties in nonaqueous solvents. Often, iron porphyrins can undergo multiple redox events making them interesting candidates for use as anolytes in asymmetrical redox flow batteries or as both catholyte and anolyte in symmetrical redox flow battery systems. Here the electrochemical properties of Fe(III)TPP species relevant to redox flow battery electrolytes are investigated including solubility, electrochemical properties, and charge/discharge cycling. Commonly used support electrolyte salts can have reactivities that are often overlooked beyond their conductivity properties in nonaqueous solvents. Parasitic reactions with the cations of common support electrolytes are highlighted herein, which underscore the careful balance required to fully assess the potential of novel RFB electrolytes.

Identifiers

PMID37342204
PMCPMC10278133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.